newsfilter
← Latest News
PR Newswire·

Lilly Completes Acquisition of Prevail Therapeutics

Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The...